Beactica AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013116
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction analysis, discovery of non-competitive ligands and allosteric sites among others. It uses SPR-based small molecule drug discovery platform for lead identification and optimization. The company works in partnership with Dong-A ST and other pharmaceutical and biotechnology companies. Beactica is headquartered in Uppsala, Sweden.

Beactica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Beactica AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Beactica Raises Funds through Venture Financing 10
Partnerships 11
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 11
Beactica Enters into Drug Discovery Agreement with Medivir 12
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 13
Beactica Enters Into Research Agreement With Janssen Research & Development 14
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Beactica Enters Into An Agreement With Janssen 16
Licensing Agreements 17
Dong-A ST Enters into Licensing Agreement with Beactica 17
Beactica AB – Key Competitors 18
Beactica AB – Key Employees 19
Beactica AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Nov 06, 2017: Beactica Appoints Erik Wallden and Uli Hacksell to its Board of Directors 21
Other Significant Developments 22
Oct 12, 2016: Beactica Participates in EU Training Network on Fragment-Based Drug Discovery 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Beactica AB, Pharmaceuticals & Healthcare, Key Facts 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beactica AB, Deals By Therapy Area, 2011 to YTD 2017 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Beactica Raises Funds through Venture Financing 10
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 11
Beactica Enters into Drug Discovery Agreement with Medivir 12
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 13
Beactica Enters Into Research Agreement With Janssen Research & Development 14
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Beactica Enters Into An Agreement With Janssen 16
Dong-A ST Enters into Licensing Agreement with Beactica 17
Beactica AB, Key Competitors 18
Beactica AB, Key Employees 19
Beactica AB, Other Locations 20

★海外企業調査レポート[Beactica AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Progenity Inc:医療機器:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • AGL Energy Limited:企業の戦略・SWOT・財務情報
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Itochu Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    Itochu Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Capstone Therapeutics Corp (CAPS):企業の財務・戦略的SWOT分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp, is a biotechnology company that develops and sells novel peptides and other molecules for helping patients with under-served medical conditions. The company develops Apo E mimetic peptide molecule AEM-28 and its analogs that ha …
  • Sanofi (SAN)-医療機器分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on researching, developing, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; huma …
  • Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • MTU Aero Engines Holdings AG (MTX):企業の財務・戦略的SWOT分析
    MTU Aero Engines Holdings AG (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Calix Ltd (CXL):企業の財務・戦略的SWOT分析
    Calix Ltd (CXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Junex Inc (JNX):企業の財務・戦略的SWOT分析
    Junex Inc (JNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Electric Power Industry of Serbia:企業の戦略的SWOT分析
    Electric Power Industry of Serbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • General Motors Company:企業の戦略・SWOT・財務情報
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Biomm SA (BIOM3):企業の財務・戦略的SWOT分析
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析
    Summary Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communicatio …
  • National Institute of Agricultural Research-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various co …
  • The Hokuetsu Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Michael J Fox Foundation for Parkinson’s Research-製薬・医療分野:企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Cydan Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cydan Development Inc (Cydan) is an orphan drug accelerator dedicated to advancing therapies for rare genetic diseases. The company identifies assets with biology and proof-of-concept data in vivo models from academic circles, industry, and other sources. It offers various technology platfor …
  • D.R. Horton Inc:戦略・SWOT・企業財務分析
    D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆